论文部分内容阅读
目的比较普康喜联合洛汀新治疗糖尿病肾病与普通方法治疗的疗效。方法随机分为两组 ,观察组 35例 ,予皮下注射胰岛素 ,口服洛汀新 1 0mg/d,普康喜 1 0 0 μg/d ,静脉滴注 ;对照组 32例 ,皮下注射胰岛素 ,口服潘生丁 ,卡托普利 ,静脉滴注低分子右旋糖酐 ,6周为一疗程。结果观察组总有效率为 86 % ,对照组总有效率为 55 % ,两组比较有显著性差异 (P <0 .0 1 )。结论普康喜联合洛汀新治疗糖尿病肾病优于对照组
Objective To compare the therapeutic effects of Pulkoxi combined with Lotensin in the treatment of diabetic nephropathy and common methods. Methods Randomly divided into two groups, the observation group of 35 cases, the subcutaneous injection of insulin, oral Lotensin new 10mg, pulutoxin 100μg / d, intravenous drip; control group of 32 patients, subcutaneous insulin injection, oral Dipyridamole, captopril, intravenous infusion of low molecular weight dextran, 6 weeks for a course of treatment. Results The total effective rate was 86% in the observation group and 55% in the control group, with significant difference between the two groups (P <0.01). CONCLUSION Pulkaxi combined with Lotensin in diabetic nephropathy is superior to the control group